Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus Clinical Trial

Official title:

Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04924777
• Other study ID #: REC/0929 Zainab Qadri
• Status: Completed
• Phase: N/A
• Start date: April 1, 2021
• Est. completion date: July 31, 2021

Study information

• Verified date: November 2021
• Source: Riphah International University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study design is to determine the effectiveness of moderate physical activity on g;lycemic control in type 2 diabetes mellitus.

Description:

To the best of authors knowledge so far the studies have been conducted on different modes of moderate physical activity on glycemic control in type 2 diabetes, current study goal is to evaluate which mode of moderate physical activity has more significant result on glycemic control in type 2 diabetes and is sustainable in Pakistani society according to the socioeconomic status and cost effectiveness of the modes of moderate physical activity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 48
• Est. completion date: July 31, 2021
• Est. primary completion date: July 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 70 Years

Eligibility

Inclusion Criteria:

• Participants falling in this category would be recruited into the study.

• Male/female

• Diabetic type 2 patients

• Age: 30-70 years

• BMI >25

• Overweight

• Fat % in male> 25

• Fat % in female >35

• HbA1c level more than 48mmol/mol or >6.5%

• Fasting Plasma Glucose level >126 mg/dl (7.0 mmol/l)

• Random Plasma glucose level >200 mg/dl (11.1 mmol/l)

• Physically active ( have no mobility problems)

Exclusion Criteria:

• Participant failing to fall in this category would be excluded of the study.

• Type 1 diabetes

• Insulin dependant type 2 diabetes

• Gestational Diabetes

• Hypertension

• Cigarette smoking

• Cardiovascular Disease

• Cerebrovascular disease

• Cardiopulmonary Disorders

• Cognition Problems

• Peripheral Artery Disease

• Dyslipidemia

• Proliferative or preproliferative retinopathy

• Nephropathy

• Neuropathy

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 2
• Type 2 Diabetes Mellitus

Intervention

Other:
• Brisk Walk
1-Brisk walk for 30 minutes 2-5 days a week 3-3months
• Strength training
1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months
• Aerobic Exercises
1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months

Locations

Country	Name	City	State
Pakistan	Riphah Rehabilitation Center	Islamabad

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HbA1c Levels	Reduction in HbA1c levels	3 months